158 related articles for article (PubMed ID: 36263167)
21. Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma.
Wang SN; Lee KT; Tsai CJ; Chen YJ; Yeh YT
Eur J Clin Invest; 2012 Dec; 42(12):1295-301. PubMed ID: 23033928
[TBL] [Abstract][Full Text] [Related]
22. Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester-induced apoptosis in C6 glioma cells.
Tseng TH; Shen CH; Huang WS; Chen CN; Liang WH; Lin TH; Kuo HC
J Biomed Sci; 2014 Jul; 21(1):61. PubMed ID: 24997497
[TBL] [Abstract][Full Text] [Related]
23. CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL; Zhang CY; Zheng WJ; Xian JR; Yang WJ; Liu T; Chen W; Li T; Wang BL; Pan BS; Li Q; Cheng JW; Wang PX; Hu B; Zhou J; Fan J; Yang XR; Guo W
Clin Transl Med; 2022 Apr; 12(4):e794. PubMed ID: 35384345
[TBL] [Abstract][Full Text] [Related]
24. Exogenous NO induces apoptosis of hepatocellular carcinoma cells via positive p38/JNK signaling pathway and negative ERK signaling pathways.
Liu L; Xing Y; Cao M; Xu J; Chen J
Mol Cell Biochem; 2021 Apr; 476(4):1651-1661. PubMed ID: 33420899
[TBL] [Abstract][Full Text] [Related]
25. Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma.
Feng IC; Hsieh MJ; Chen PN; Hsieh YH; Ho HY; Yang SF; Yeh CB
Environ Toxicol; 2018 Mar; 33(3):261-268. PubMed ID: 29159945
[TBL] [Abstract][Full Text] [Related]
26. Anticancer drugs induce hypomethylation of the acetylcholinesterase promoter via a phosphorylated-p38-DNMT1-AChE pathway in apoptotic hepatocellular carcinoma cells.
Xi Q; Gao N; Yang Y; Ye W; Zhang B; Wu J; Jiang G; Zhang X
Int J Biochem Cell Biol; 2015 Nov; 68():21-32. PubMed ID: 26299326
[TBL] [Abstract][Full Text] [Related]
27. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
[TBL] [Abstract][Full Text] [Related]
28. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
30. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
[TBL] [Abstract][Full Text] [Related]
31. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
[TBL] [Abstract][Full Text] [Related]
33. Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cells.
Wang Y; Wang W; Wang L; Wang X; Xia J
J Cell Mol Med; 2012 Mar; 16(3):496-506. PubMed ID: 21545687
[TBL] [Abstract][Full Text] [Related]
34. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
[TBL] [Abstract][Full Text] [Related]
35. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death.
Zahid KR; Han S; Zhou F; Raza U
Cell Oncol (Dordr); 2019 Feb; 42(1):55-66. PubMed ID: 30238408
[TBL] [Abstract][Full Text] [Related]
36. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
37. Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis.
Harrington AW; Kim JY; Yoon SO
J Neurosci; 2002 Jan; 22(1):156-66. PubMed ID: 11756498
[TBL] [Abstract][Full Text] [Related]
38. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
[TBL] [Abstract][Full Text] [Related]
39. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]